12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · 03/19 17:06
Gainers
- Black Diamond Therapeutic (NASDAQ:BDTX) stock moved upwards by 29.1% to $2.17 during Wednesday's regular session. The company's market cap stands at $122.9 million.
- Lyell Immunopharma (NASDAQ:LYEL) shares moved upwards by 23.13% to $0.6. The company's market cap stands at $175.8 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 22.58% to $2.47. The market value of their outstanding shares is at $1.6 million.
- TuHURA Biosciences (NASDAQ:HURA) shares moved upwards by 17.85% to $3.3. The company's market cap stands at $139.5 million.
- Venus Concept (NASDAQ:VERO) stock moved upwards by 17.37% to $3.35. The company's market cap stands at $2.2 million.
- Scienture Holdings (NASDAQ:SCNX) stock rose 16.98% to $1.86. The market value of their outstanding shares is at $16.0 million.
Losers
- Tonix Pharmaceuticals (NASDAQ:TNXP) shares fell 19.9% to $16.45 during Wednesday's regular session. The company's market cap stands at $91.9 million. The company's, Q4 earnings came out yesterday.
- Intensity Therapeutics (NASDAQ:INTS) stock decreased by 17.91% to $1.88. The market value of their outstanding shares is at $28.5 million. As per the press release, Q4 earnings came out 4 days ago.
- HealthEquity (NASDAQ:HQY) stock declined by 17.54% to $83.84. The market value of their outstanding shares is at $7.2 billion. As per the press release, Q4 earnings came out yesterday.
- Can Fite Biofarma (AMEX:CANF) stock decreased by 16.84% to $1.68. The company's market cap stands at $8.3 million.
- OmniAb (NASDAQ:OABI) shares decreased by 15.84% to $2.69. The market value of their outstanding shares is at $324.9 million. As per the news, the Q4 earnings report came out yesterday.
- vTv Therapeutics (NASDAQ:VTVT) stock fell 14.49% to $17.95. The company's market cap stands at $46.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.